コンテンツへスキップ
Merck

[Syphilis].

Presse medicale (Paris, France : 1983) (2013-02-19)
Nicolas Dupin, David Farhi
要旨

Syphilis is back since 2000. Early syphilis comprises primary syphilis, secondary syphilis and early latent syphilis (less than 1 year duration). During early phases of syphilis, patients are more contagious and neurologic complications are rare. Early neurosyphilis are mostly represented by uveitis or cranial nerves lesions. Treatment of non-neurologic syphilis are based on intramusculary injection of benzathine-penicilline G: one injection in case of early syphilis, three injections in case of late syphilis. The follow-up after treatment is based on clinical evolution and the titer of VDRL. Intravenously infusion of penicillin G is the only treatment recommended for neurosyphilis.

材料
製品番号
ブランド
製品内容

Sigma-Aldrich
ペニシリンG ナトリウム塩, powder, BioReagent, suitable for cell culture
Sigma-Aldrich
ペニシリンG カリウム塩, powder, BioReagent, suitable for cell culture
Sigma-Aldrich
ペニシリンG ナトリウム塩, 96.0-102.0%
Sigma-Aldrich
ペニシリンG ナトリウム塩, ~1650 U/mg
Sigma-Aldrich
ペニシリンG カリウム塩, 95.0 - 102.0%
Sigma-Aldrich
ペニシリンG カリウム塩
Supelco
ペニシリンG カリウム塩, VETRANAL®, analytical standard